Ticker > Company >

Vivanza Biosciences share price

Vivanza Biosciences Ltd.

BSE: 530057 SECTOR: Trading  10k   10   1

2.08
0 0
BSE: 09 May 04:01 PM

Price Summary

Today's High

₹ 2.14

Today's Low

₹ 2.04

52 Week High

₹ 7.65

52 Week Low

₹ 1.9

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8.32 Cr.

Enterprise Value

11.49 Cr.

No. of Shares

4 Cr.

P/E

0

P/B

1.67

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.25

CASH

0.09 Cr.

DEBT

3.26 Cr.

Promoter Holding

20.02 %

EPS (TTM)

₹  -0.03

Sales Growth

1.45%

ROE

6.97 %

ROCE

8.96%

Profit Growth

-44.23 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1.45%
3 Year16.04%
5 Year45.36%

Profit Growth

1 Year-44.23%
3 Year47.03%
5 Year22.04%

ROE%

1 Year6.97%
3 Year11.23%
5 Year6.13%

ROCE %

1 Year8.96%
3 Year11.94%
5 Year11.94%

Debt/Equity

0.692

Price to Cash Flow

4.63

Interest Cover Ratio

2.0219

CFO/PAT (5 Yr. Avg.)

0.800297792942996

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 20.02 0.00
Dec 2024 20.02 0.00
Sep 2024 39.86 0.00
Jun 2024 40.05 0.00
Mar 2024 43.24 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 16.0440910083725% for the Past 3 years.
  • The company has significantly decreased its debt by 3.3014 Cr.

 Limitations

  • Company has high debtor days of 285.5409.
  • The company has a low EBITDA margin of 1.97742379144488% over the past 5 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 32.1606.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 3.37 2.3 0.43 1.58 0.76
Total Expenditure 3.1 2.43 0.11 1.48 0.64
Operating Profit 0.27 -0.14 0.32 0.1 0.12
Other Income 0.02 -0.03 0 0 0.01
Interest 0.1 0.09 0.09 0.09 0.09
Depreciation 0 0.01 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.18 -0.27 0.23 0.01 0.04
Tax 0 0.11 0 0 0
Profit After Tax 0.18 -0.38 0.23 0.01 0.04
Adjusted EPS (Rs) 0.05 -0.09 0.06 0 0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 9.37 9.22 9.15 14.21 14.41
Total Expenditure 9.66 9.09 9.07 13.47 13.61
Operating Profit -0.3 0.13 0.07 0.74 0.81
Other Income 0.53 0.5 0.83 0.39 0.05
Interest 0.44 0.47 0.43 0.43 0.42
Depreciation 0 0.01 0.01 0 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.2 0.15 0.46 0.69 0.43
Tax 0 0.05 0 0.12 0.11
Net Profit -0.2 0.1 0.46 0.57 0.32
Adjusted EPS (Rs.) -0.05 0.03 0.12 0.14 0.08

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4 4 4 4 4
Total Reserves -0.73 -0.63 -0.17 0.4 0.72
Borrowings 0 0 0 0 0.78
Other N/C liabilities 0 0 0 0 0
Current liabilities 9.01 4.57 10.38 16.04 11.38
Total Liabilities 12.28 7.93 14.21 20.44 16.87
Assets
Net Block 0 0.01 0 0 0.03
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 1.91 1.91 1.91 1.91 1.91
Loans & Advances 0.59 0.59 0.59 0.59 0.59
Other N/C Assets 0 0 0 0 0
Current Assets 9.77 5.41 11.7 17.93 14.33
Total Assets 12.28 7.93 14.21 20.44 16.87
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.2 0.15 0.46 0.69 0.43
Adjustment 0.44 0.48 0.41 0.42 0.43
Changes in Assets & Liabilities 2.56 -3.65 -1.55 -0.83 1.05
Tax Paid 0 -0.05 0 -0.12 -0.11
Operating Cash Flow 2.8 -3.08 -0.68 0.16 1.8
Investing Cash Flow 0 -0.02 0 0 -0.04
Financing Cash Flow -2.58 2.8 0.65 -0.08 -1.77
Net Cash Flow 0.22 -0.3 -0.03 0.09 -0.01

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 43.24 40.05 39.86 20.02 20.02
hemant amrish parikh 0.25 0.25 0.25 0.25 0.25
parth hemant parikh 42.99 39.80 39.61 19.77 19.77
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 56.76 59.95 60.14 79.98 79.98
ammishi m desai - - - 1.50 1.39
ashoka metcast limited - 14.08 7.75 3.85 3.85
llp - - - - 0.03
prashant tyagi - - - - 1.51
kalpesh vithaldas rami - - - 1.06 -
swati vishal suthar - - - 1.53 -
vishal chinubhai suthar h... - - - 2.85 -
ardent ventures llp 23.09 - - - -
ashoka metcast ltd 19.37 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Vivanza Biosciences informs about updates 2 May, 4:09 PM Vivanza Biosciences informs about compliance certificate 3 Apr, 3:15 PM Vivanza Biosciences informs about trading window closure 22 Mar, 3:46 PM Vivanza Biosciences informs about appointment of CS cum CO 20 Mar, 5:25 PM Vivanza Biosciences informs about outcome of board meeting 20 Mar, 4:34 PM Vivanza Biosciences informs about newspaper publication 1 Feb, 3:14 PM Vivanza Biosciences - Quaterly Results 31 Jan, 4:41 PM Vivanza Biosciences - Quaterly Results 31 Jan, 4:41 PM Vivanza Biosciences - Quaterly Results 31 Jan, 4:41 PM Vivanza Biosciences informs about disclosure 20 Dec, 1:02 PM Vivanza Biosciences informs about disclosure 5 Dec, 2:37 PM Vivanza Biosciences informs about disclosure 7 Nov, 10:24 AM Vivanza Biosciences informs about updates 4 Nov, 3:45 PM Vivanza Biosciences informs about disclosure 30 Oct, 11:45 AM Vivanza Biosciences informs about disclosure 18 Oct, 12:29 PM Vivanza Biosciences - Quaterly Results 17 Oct, 5:32 PM Vivanza Biosciences - Quaterly Results 17 Oct, 5:32 PM Vivanza Biosciences - Quaterly Results 17 Oct, 5:32 PM Vivanza Biosciences - Quaterly Results 8 Aug, 6:20 PM Vivanza Biosciences - Quaterly Results 8 Aug, 6:20 PM Vivanza Biosciences - Quaterly Results 8 Aug, 6:20 PM Vivanza Biosciences informs about disclosure 9 Jul, 4:48 PM Vivanza Biosciences informs about disclosures 3 Jun, 3:06 PM Vivanza Biosciences - Quaterly Results 30 Apr, 5:12 PM Vivanza Biosciences - Quaterly Results 30 Apr, 5:12 PM Vivanza Biosciences - Quaterly Results 30 Apr, 5:12 PM Vivanza Biosciences informs about non-applicability of statement of deviation or variation 11 Apr, 4:17 PM Vivanza Biosciences informs about disclosure 26 Feb, 3:11 PM Vivanza Biosciences informs about disclosures 23 Feb, 12:32 PM Vivanza Biosciences informs about disclosure 22 Feb, 2:20 PM Vivanza Biosciences informs about disclosure 22 Feb, 2:20 PM Vivanza Biosciences - Quaterly Results 6 Feb, 4:26 PM Vivanza Biosciences - Quaterly Results 6 Feb, 4:26 PM Vivanza Biosciences - Quaterly Results 6 Feb, 4:26 PM Vivanza Biosciences informs about disclosure 4 Jan, 9:46 AM Vivanza Biosciences informs about disclosure 7 Dec, 2:38 PM Vivanza Biosciences informs about disclosures 4 Nov, 2:45 PM Vivanza Biosciences - Quaterly Results 26 Oct, 4:33 PM Vivanza Biosciences - Quaterly Results 26 Oct, 4:33 PM Vivanza Biosciences - Quaterly Results 26 Oct, 4:33 PM Vivanza Biosciences informs about compliances-certificate 17 Oct, 5:08 PM Vivanza Biosciences informs about outcome of board meeting 1 Sep, 3:42 PM Vivanza Biosciences informs about AGM 26 Jul, 1:23 PM Vivanza Biosciences informs about outcome of Board Meeting 1 Jul, 2:13 PM Vivanza Biosciences informs about board meeting outcome 1 Jul, 12:26 PM Vivanza Biosciences informs about press release 27 Apr, 3:23 PM Vivanza Biosciences - Quaterly Results 25 Apr, 7:08 PM Vivanza Biosciences - Quaterly Results 25 Apr, 7:08 PM Vivanza Biosciences informs about outcome of board meeting 4 Mar, 12:54 PM Vivanza Biosciences informs about scrutinizer report on e-voting 25 Feb, 2:36 PM

Vivanza Biosciences Stock Price Analysis and Quick Research Report. Is Vivanza Biosciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Vivanza Biosciences stock price today is Rs 2.08. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vivanza Biosciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vivanza Biosciences has a PE ratio of -74.8201438848921 which is low and comparatively undervalued .

  • Share Price: - The current share price of Vivanza Biosciences is Rs 2.08. One can use valuation calculators of ticker to know if Vivanza Biosciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vivanza Biosciences has ROA of 1.7015 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vivanza Biosciences has a Current ratio of 1.2596 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vivanza Biosciences has a ROE of 6.9657 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Vivanza Biosciences has a Debt to Equity ratio of 0.692 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Vivanza Biosciences has reported revenue growth of 1.4507 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Vivanza Biosciences for the current financial year is 5.59556517636611 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vivanza Biosciences is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vivanza Biosciences is Rs -0.0278 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vivanza Biosciences in Ticker for free. Also, one can get the intrinsic value of Vivanza Biosciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Vivanza Biosciences
X